NEWS TIPS & FEATURES

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy... [...]


Kyprolis® Significantly Improves Overall Survival Compared To Velcade® In Relapsed Or Refractory Multiple Myeloma

The ENDEAVOR trial results were updated at the 16th International Myeloma Workshop in New Delhi.  The trial demonstrated that Kyprolis (Carfilzomib) not only significantly extended progression-free survival... [...]


Goodbye Brain Fog! Strategies to Help Get Your Thinking Back on Track

Have a Question about Cancer-Related Brain Fog? Ask the Expert! Live Web Chat Tuesday, March 28th, 4:00-5:00 PM, EST Tune in here. Join us for a live Ask the Expert session with neurocognitive expert Heather... [...]


March is Multiple Myeloma Awareness Month: Learn About Recent Advances

There are several recent advances of note in the management of all stages of Multiple Myeloma. Smoldering myeloma is considered to be a pre-cancerous condition, in which patients do not yet display any... [...]


Lynparza Improves Progression-Free Survival in BRCA-Mutated Ovarian Cancer

Results were recently presented at the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer in National Harbor, USA, demonstrating that Lynparza (olaparib) reduced the risk of platinum-sensitive,... [...]


Kisqali® Receives FDA Approval as First Line Treatment for HR+/HER2- Metastatic Breast Cancer

The US Food and Drug Administration (FDA) has approved the investigational drug Kisqali® (ribociclib, LEE011) for first line treatment of hormone receptor + HER 2- metastatic breast cancer because when... [...]


Regional Chemotherapy Technique for Extremity Sarcoma Salvages Patients’ Limbs from Amputation

Patients with a type of advanced malignant cancer of the arms or legs have typically faced amputation of the afflicted limb as the only treatment option.  However, a technique that limits the application... [...]


Newly Diagnosed with Ovarian Cancer? 10 Must Read Empowered Patient Tips

For many years ovarian cancer has been referred to as “the silent killer” due to its vague, ignored, or misdiagnosed symp­toms. Because of this and the lack of ear­ly-detection tools, ovarian cancer... [...]


COMBI-v BRAF/MEK Inhibitor Combination Trial Continues to Impress in Melanoma

For advanced melanoma patients with BRAF mutations, two pathway inhibitors are much better than one, according to a study presented at the European Society for Medical Oncology.  The latest data confirm... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS